Clinical Trial Update: University of Texas H.S.C. San Antonio Pioglitazone in Non-Alcoholic Steatohepatitis Trial (UTHSCSA NASH Trial) [Phase 4]

View source ↗

Summary

This entry reports the completion of a Phase 4 trial evaluating pioglitazone for nonalcoholic steatohepatitis (NASH) and related fatty liver disease. The study …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nonalcoholic Fatty Liver Disease
• Nonalcoholic Steatohepatitis
• Type 2 Diabetes Mellitus

Drugs mentioned

• PIOGLITAZONE (Pioglitazone)

Snippet

Sponsor: University of Florida | Conditions: Nonalcoholic Steatohepatitis, Nonalcoholic Fatty Liver Disease | Phase 4 | Status: COMPLETED | Results posted: 2017-04-05